Mersana Therapeutics (MRSN) News Today $0.30 +0.01 (+1.72%) As of 06/30/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MRSN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual MeetingJune 2, 2025 | globenewswire.comMersana Therapeutics to Present at Upcoming Investor ConferencesMay 20, 2025 | globenewswire.comQ1 2025 Mersana Therapeutics Inc Earnings CallMay 16, 2025 | uk.finance.yahoo.comMersana Therapeutics Inc (MRSN) Q1 2025 Earnings Call Highlights: Strategic Restructuring and ...May 16, 2025 | finance.yahoo.comMersana extends cash runway into mid-2026 as restructuring narrows focus to breast cancerMay 15, 2025 | msn.comCORRECTION - Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial ResultsMay 15, 2025 | finance.yahoo.comCORRECTION - Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial ResultsMay 15, 2025 | globenewswire.comMersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial ResultsMay 15, 2025 | finance.yahoo.comMersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial ResultsMay 15, 2025 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Mersana Therapeutics (MRSN) and IQVIA Holdings (IQV)May 9, 2025 | theglobeandmail.comMersana Therapeutics announces strategic cutbacks amid economic pressuresMay 7, 2025 | investing.comMersana Therapeutics Announces Strategic Restructuring and Reprioritization Plan Focused on Advancing Emi-Le in Triple-Negative Breast CancerMay 6, 2025 | globenewswire.com4,250,000 Shares in Mersana Therapeutics, Inc. (NASDAQ:MRSN) Purchased by Novo Holdings A SMay 3, 2025 | marketbeat.comMersana Therapeutics (MRSN) Expected to Announce Earnings on ThursdayMay 3, 2025 | marketbeat.comMersana Therapeutics Announces Upcoming Emi-Le Oral and Poster Presentations at ASCO 2025 Annual MeetingApril 23, 2025 | globenewswire.comMersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual CongressApril 1, 2025 | globenewswire.comMersana at Leerink Global Healthcare Conference: Strategic ADC InsightsMarch 13, 2025 | investing.comMersana Therapeutics, Inc. (NASDAQ:MRSN) Given Consensus Recommendation of "Moderate Buy" by BrokeragesMarch 13, 2025 | marketbeat.comQ1 EPS Estimates for Mersana Therapeutics Cut by WedbushMarch 7, 2025 | marketbeat.comWhat is William Blair's Estimate for MRSN Q1 Earnings?March 7, 2025 | marketbeat.comEarnings Update: Mersana Therapeutics, Inc. (NASDAQ:MRSN) Just Reported And Analysts Are Boosting Their EstimatesMarch 6, 2025 | finance.yahoo.comWhat is Leerink Partnrs' Forecast for MRSN FY2025 Earnings?March 6, 2025 | marketbeat.comIndustry Analysts Just Made A Captivating Upgrade To Their Mersana Therapeutics, Inc. (NASDAQ:MRSN) Revenue ForecastsMarch 5, 2025 | finance.yahoo.comMersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2024 Earnings Call TranscriptMarch 4, 2025 | insidermonkey.comAnalysts Set Expectations for MRSN Q1 EarningsMarch 4, 2025 | marketbeat.comWedbush Reaffirms Outperform Rating for Mersana Therapeutics (NASDAQ:MRSN)March 3, 2025 | marketbeat.comMersana Therapeutics, Inc.: Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial ResultsMarch 3, 2025 | finanznachrichten.deMersana Therapeutics reports Q4 EPS (11c), consensus (17c)March 3, 2025 | markets.businessinsider.comMersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial ResultsMarch 3, 2025 | finance.yahoo.comMersana Therapeutics (NASDAQ:MRSN) Posts Earnings Results, Beats Expectations By $0.05 EPSMarch 3, 2025 | marketbeat.comMersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial ResultsMarch 3, 2025 | globenewswire.comMersana Therapeutics faces Nasdaq delisting over share priceMarch 2, 2025 | uk.investing.comMersana Therapeutics Q4 2024 Earnings PreviewFebruary 28, 2025 | msn.comMersana Therapeutics to Present at Upcoming Investor ConferencesFebruary 25, 2025 | globenewswire.comMersana Therapeutics to Host Fourth Quarter and Year End 2024 Conference Call on March 3, 2025February 24, 2025 | globenewswire.comMersana Therapeutics (MRSN) Expected to Announce Earnings on WednesdayFebruary 19, 2025 | marketbeat.comMersana Therapeutics, Inc. (NASDAQ:MRSN) Given Average Rating of "Moderate Buy" by AnalystsFebruary 16, 2025 | marketbeat.comWhat is William Blair's Estimate for MRSN FY2024 Earnings?February 10, 2025 | marketbeat.comMersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)February 7, 2025 | globenewswire.comWilliam Blair starts Mersana stock with Outperform ratingFebruary 6, 2025 | msn.comWilliam Blair Initiates Coverage of Mersana Therapeutics (MRSN) with Outperform RecommendationFebruary 6, 2025 | msn.comMersana Therapeutics (NASDAQ:MRSN) Coverage Initiated at William BlairFebruary 6, 2025 | marketbeat.comMersana Therapeutics initiated with an Outperform at William BlairFebruary 6, 2025 | markets.businessinsider.comMersana Therapeutics to Participate in the Guggenheim SMID Cap Biotech ConferenceJanuary 30, 2025 | globenewswire.comBrokerages Set Mersana Therapeutics, Inc. (NASDAQ:MRSN) Price Target at $5.57January 25, 2025 | marketbeat.comMRSN stock touches 52-week low at $0.56 amid market challengesJanuary 21, 2025 | msn.comMersana Therapeutics CEO sells $2,618 in stockJanuary 18, 2025 | msn.comMersana Therapeutics chief development officer sells shares worth $3,444January 18, 2025 | msn.comMersana Therapeutics' chief accounting officer sells shares worth $2,061January 17, 2025 | msn.comMersana Therapeutics officer Timothy Lowinger sells $4,667 in stockJanuary 17, 2025 | msn.com Get Mersana Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MRSN and its competitors with MarketBeat's FREE daily newsletter. Email Address MRSN Media Mentions By Week MRSN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRSN News Sentiment▼1.870.90▲Average Medical News Sentiment MRSN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRSN Articles This Week▼12▲MRSN Articles Average Week Get Mersana Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MRSN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVCT News Today PBYI News Today IPHA News Today SPRO News Today VYGR News Today ALTS News Today EPRX News Today GALT News Today DMAC News Today ELDN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRSN) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mersana Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mersana Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
